News Novo's Wegovy pill cleared for weight loss in EU The EU has approved Novo Nordisk's pill formulation of weight-loss therapy Wegovy, keeping the company a step ahead of arch rival Eli Lilly.
News Kailera's big obesity reveal puts pressure on shares Fresh from a record-breaking IPO, Kailera revealed keenly anticipated trial results for its oral weight-loss drug, to a mixed reaction.
News Obesity biotech Kalohexis files confidential IPO Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO.
News Almost half of dementia cases could be prevented, says study A study has found that nearly half of all cases of dementia are avoidable with lifestyle changes, but current education campaigns have limited effect.
News UK partners with Eli Lilly on obesity plan The UK has teamed up with Eli Lilly on initiatives, backed with £85 million in funding, to expand access to treatment for obesity.
News Obesity is rising fastest in young adults in England An analysis of around 54m health records in England has revealed rising rates of obesity, particularly among young adults and disadvantaged groups.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.